Navigation Links
Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025
Date:5/4/2010

3.1 The Global Pain Market: Analysis and Forecast

3.2 Sub-Market Categories of the Global Pain Drug Market

3.2.1 Oxycontin Currently Leads the Global Pain Drug Market

3.2.2 The Anti-Epileptics Segment: Will its Success Last?

3.3 Success in the Pain Relieving Drug Market Has Proved Challenging

3.4 While the Past Has Been Difficult for Pain Management, There is Optimism for the Future

4. The Global Narcotics Market 2010-2025

4.1 The Narcotics Market Analysis and Forecast

4.2 Oxycontin – Therapeutic and Commercial Challenges

4.2.1 Development of Oxycontin (Oxycodone)

4.3 Duragesic (Fentanyl) – Challenges in the Market

4.3.1 Development of Duragesic (Fentanyl)

4.4 Fentanyl MYLA Will Show Strong Revenues

4.4.1 Fentanyl

4.5 Actiq Fighting a Decline in Sales

4.5.1 Actiq (Fentanyl Citrate)

4.6 Other Agents

4.7 Total Sales in the Narcotics Market Will Increase, Despite its Being Crowded

5. The Global Non-Narcotics Market 2010-2025

5.1 The Non-Narcotics Market Analysis and Forecast

5.2 Efferalgan is Currently the Non-Narcotic Market's Leading Drug

5.2.1 Development of Efferalgan (Paracetamol/Acetaminophen)

5.3 Tylenol – a Future Blockbuster of the Non-Narcotics Market?

5.3.1 Development of Tylenol (Paracetamol/Acetaminophen)


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Reportlinker Adds The Outlook for Pharmaceuticals in Western Europe
2. Reportlinker Adds Atherosclerosis Or Coronary Artery Disease (CAD) - Drug Pipeline Analysis and Market Forecasts to 2016
3. Reportlinker Adds U.S. Market for Hearing Aids and Audiology Devices 2010 (Includes Audiologist Survey)
4. Reportlinker Adds Atrial Fibrillation - Drug Pipeline Analysis and Market Forecasts to 2016
5. Reportlinker Adds World Wound Management Products
6. Reportlinker Adds Negative Pressure Wound Therapy (NPWT) Pipeline Technology and Market Forecasts to 2016
7. Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition]
8. Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015
9. Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015
10. Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile
11. Reportlinker Adds Top Ten Worlds Leading Orthopedics Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... July 30, 2015 ... reports analyzing tumor biomarker tests, imaging, endoscopy ... for the global industry by technology and ... Industry (Tumor Biomarker Tests, Imaging, Endoscopy and ... talking about 9 companies and supported with ...
(Date:7/29/2015)... OSAKA, Japan , ... -- ... confirmed,   including Core ... EPS    ... Underlying revenue +6.1% year-to-year (reported revenue growing +8.5% to 446.3 billion yen) ...
(Date:7/29/2015)... Ill. , July 30, 2015  Astellas ... ACTIVE study evaluating the efficacy and safety of ... CRESEMBA® (isavuconazonium sulfate), under development for adults with ... Results from the study demonstrated that the trial ... in overall treatment response in isavuconazole-treated patients at ...
Breaking Medicine Technology:Cancer Diagnostics Market to see 12% CAGR to 2020: Analysis of Tumor Biomarker Tests, Imaging, Endoscopy, Biopsy and More in New Research Reports 2Cancer Diagnostics Market to see 12% CAGR to 2020: Analysis of Tumor Biomarker Tests, Imaging, Endoscopy, Biopsy and More in New Research Reports 3Cancer Diagnostics Market to see 12% CAGR to 2020: Analysis of Tumor Biomarker Tests, Imaging, Endoscopy, Biopsy and More in New Research Reports 4Cancer Diagnostics Market to see 12% CAGR to 2020: Analysis of Tumor Biomarker Tests, Imaging, Endoscopy, Biopsy and More in New Research Reports 5Cancer Diagnostics Market to see 12% CAGR to 2020: Analysis of Tumor Biomarker Tests, Imaging, Endoscopy, Biopsy and More in New Research Reports 6Takeda Reports 1st Quarter Results of FY2015 with Underlying Revenue Growth of +6.1% 2Takeda Reports 1st Quarter Results of FY2015 with Underlying Revenue Growth of +6.1% 3Takeda Reports 1st Quarter Results of FY2015 with Underlying Revenue Growth of +6.1% 4Takeda Reports 1st Quarter Results of FY2015 with Underlying Revenue Growth of +6.1% 5Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 2Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 3Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 4Astellas Provides Update on Phase 3 Study Evaluating Isavuconazole in Patients with Candidemia and Other Invasive Candida Infections 5
... Dec. 8 Cell Therapeutics, Inc. (CTI),(Nasdaq ... follow-up data for the,Zevalin(R) ([90Y]-ibritumomab tiuxetan) First-line ... of Hematology (ASH) 50th Annual Meeting by,Morschhauser, ... progression-free,survival (PFS) following Zevalin consolidation therapy for ...
... 7 Millennium: The Takeda Oncology,Company today ... randomized, multi-center,Company-sponsored Phase I/II study of VELCADE, ... previously untreated multiple,myeloma (MM). The preliminary analysis ... of four drugs was generally well tolerated ...
Cached Medicine Technology:Zevalin Consolidation in Patients With Complete Remission After Induction Therapy Results in Durable Remission of More Than 67 Months 2Zevalin Consolidation in Patients With Complete Remission After Induction Therapy Results in Durable Remission of More Than 67 Months 3Zevalin Consolidation in Patients With Complete Remission After Induction Therapy Results in Durable Remission of More Than 67 Months 4Zevalin Consolidation in Patients With Complete Remission After Induction Therapy Results in Durable Remission of More Than 67 Months 5Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients 2Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients 3Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients 4Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients 5Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients 6
(Date:7/30/2015)... ... ... " DevExpress ” was featured on NewsWatch as part ... large businesses making an impact in their industry. Susan Bridges, a reporter for ... how DevExpress has provided software development tools that have helped app developers build ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... 24/7 Care ... Angeles, Riverside, and San Bernardino, recently announced that the Centers for Medicare and Medicaid ... system of home health care providers. 24/7 Care At Home’s agency is one of ...
(Date:7/30/2015)... ... July 30, 2015 , ... The need for accessibility ... effort to provide comfort to patients as well as visiting friends and family during ... phone charging stations. , The stations - powered by ChargeItSpot , a Philadelphia-based ...
(Date:7/30/2015)... ... July 30, 2015 , ... OncLive®’s ... and UCLA’s Jonsson Comprehensive Cancer Center (JCCC) mutually agreed to collaborate ... collaboration, OncLive’s editorial and marketing groups will help spread the news about the ...
(Date:7/30/2015)... ... , ... Zejax is a New Way of Training Without ... , World renown body weight trainer, Paul Ziachik, announces today that he is ... person’s training capability. , The American College of Sports Medicine states that among ...
Breaking Medicine News(10 mins):Health News:Software to Develop High-Performance Data-Driven Apps was Featured on NewsWatch Television 2Health News:24/7 Care At Home Earns a 5-Star Rating from the Centers for Medicare and Medicaid (CMS) 2Health News:Hospitals Add Phone Charging Stations as an Amenity for Patients and Visitors 2Health News:UCLA Jonsson Comprehensive Cancer Center Teams with OncLive® as a Strategic Alliance Partner 2Health News:UCLA Jonsson Comprehensive Cancer Center Teams with OncLive® as a Strategic Alliance Partner 3Health News:UCLA Jonsson Comprehensive Cancer Center Teams with OncLive® as a Strategic Alliance Partner 4Health News:Zejax is a Revolutionary New Way of BodyWeight Training Without Weights 2
... country Myanmar did not give him more than six months ... life in a Delhi hospital which successfully conducted a live ... 10-hour liver transplant surgery at the Sir Ganga Ram Hospital, ... ago and is now getting ready to return home. ...
... care of patients of Scotland hospitals causing an imbalance in ... official watchdog to ensure //that the standards of effective dietary ... Audit report 50% of the hospitals have not yet analyzed ... who are in a critical condition and any miscalculation in ...
... their hearts face risks. The devices called stents.Stents are used ... passage of// blood. It is inserted into cardiac arteries by ... with drugs are more liable to suffer from internal blood ... compared to patients who use stents that are not medicated. ...
... research keenly studied the effect of discontinuing HIV drug therapy ... can be positively// devastating, reported the study. New England Journal ... in its Nov 30 issue. If the treatment is discontinued, ... AIDS and also suffer from toxic side effects of the ...
... used drugs that are used in treatment of cancer, ... by a research, published by the Journal of Biology.// ... brain damage. The effects may be long lasting. This ... refers to the side effects that are seen in ...
... consume junk food which is over laden with salt especially ... This has resulted in// a difficulty for them to consume ... are used to high salt intake. ,Disasters like ... which ruin the lives of many and can be corrected ...
Cached Medicine News:Health News:Myanmar National Undergoes Successful Liver Transplantation in Delhi 2Health News:Hospital Food Needs Improvement to Meet the Nutritional Needs of the Patient 2Health News:Using Heart Stents Tends to Form More Clots 2Health News:Interrupted Treatment Dangerous to HIV Management 2
... includes: Mx3005P instrument and custom filter ... (5) filters. The standard filter set ... (535nm-555nm), ROX/Texas Red (585nm-610nm), Cy5 (635nm-665nm) ... computer, Mx3005P analysis software, Beacon Designer ...
... a rapid, real-time thermal cycler used for ... automating much of the testing process, and ... is the fastest, easiest to use, and ... The SmartCycler delivers highly accurate and consistent ...
... System is a rapid, real-time thermal cycler ... samples. By automating much of the testing ... programmable, it is the fastest, easiest to ... the market. The SmartCycler delivers highly accurate ...
... Time Thermal Block and its operation ... as quantification of gene expression, genotyping, ... validation of microarray results. Exicycler is ... two molecules, such as protein-protein and ...
Medicine Products: